Gilead Sciences is trading at ARS 73,250.00, up 4.42%, as biotech stocks rally.
- XBI is up 2.13% amid rotation away from technology.
- Major indices are also higher, reflecting positive broad-market sentiment.
- Gilead announced plans to present 23 presentations at the upcoming ASH meeting on November 4; available reporting does not establish this as the cause of the move.